Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRKCA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LARP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETFBKMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFADN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAPPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCNU1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf57 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01122 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM179A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4E3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL12RB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2DNL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIR2DL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on